You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR BRINZOLAMIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for BRINZOLAMIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00121147 ↗ Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan Completed Alcon Research N/A 2003-09-01 The purpose of this study is to compare the additive effect on eye pressure of Azopt and Alphagan P to Travatan.
NCT00121147 ↗ Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan Completed Hermann Eye Center N/A 2003-09-01 The purpose of this study is to compare the additive effect on eye pressure of Azopt and Alphagan P to Travatan.
NCT00300079 ↗ Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension Completed University of California, San Diego Phase 4 2006-09-01 This is a multiple-dose study of the IOP-lowering efficacy of Azopt (brinzolamide) 1.0% compared to timolol 0.5% when added to a prostaglandin analogue (PGA) as adjunctive therapy over a 24 hour period in patients with glaucoma or ocular hypertension.
NCT00300079 ↗ Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension Completed Alcon Research Phase 4 2006-09-01 This is a multiple-dose study of the IOP-lowering efficacy of Azopt (brinzolamide) 1.0% compared to timolol 0.5% when added to a prostaglandin analogue (PGA) as adjunctive therapy over a 24 hour period in patients with glaucoma or ocular hypertension.
NCT00372827 ↗ Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension Completed Alcon Research Phase 4 2004-02-01 The purpose of the study is to compare the efficacy and safety of Timolol 0.5% solution to Brinzolamide 1% each given twice daily when added to Travoprost 0.004% given each evening.
NCT00382226 ↗ IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy Completed Alcon Research Phase 4 2006-09-01 Uncontrolled glaucoma patients being treated with a prostaglandin agent alone or in combination with adjunctive drugs in fixed or unfixed combinations, will be switched from their current therapy to travoprost/timolol fixed combination and either Azopt or placebo
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for BRINZOLAMIDE

Condition Name

Condition Name for BRINZOLAMIDE
Intervention Trials
Ocular Hypertension 34
Glaucoma 22
Open-Angle Glaucoma 14
Open Angle Glaucoma 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for BRINZOLAMIDE
Intervention Trials
Glaucoma 42
Ocular Hypertension 37
Hypertension 28
Glaucoma, Open-Angle 26
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for BRINZOLAMIDE

Trials by Country

Trials by Country for BRINZOLAMIDE
Location Trials
United States 38
Greece 4
Germany 2
Brazil 2
Italy 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for BRINZOLAMIDE
Location Trials
Texas 8
California 5
Georgia 3
Florida 3
Illinois 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for BRINZOLAMIDE

Clinical Trial Phase

Clinical Trial Phase for BRINZOLAMIDE
Clinical Trial Phase Trials
Phase 4 27
Phase 3 15
Phase 2 6
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for BRINZOLAMIDE
Clinical Trial Phase Trials
Completed 40
Terminated 6
Unknown status 3
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BRINZOLAMIDE

Sponsor Name

Sponsor Name for BRINZOLAMIDE
Sponsor Trials
Alcon Research 33
University Hospital of Patras 2
Bausch & Lomb Incorporated 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for BRINZOLAMIDE
Sponsor Trials
Industry 47
Other 15
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.